gliclazide


Also found in: Wikipedia.

gliclazide

 [glik´lah-zīd]
a sulfonylurea compound used as a hypoglycemic agent in treatment of type 2 diabetes mellitus.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

gliclazide

A SULPHONYLUREA drug used to treat maturity onset (Type II) DIABETES. A brand name is Diamicron.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005
Mentioned in ?
References in periodicals archive ?
Mayor Dino Chua said the town's senior citizens could avail themselves of common maintenance drugs, such as Lozartan 50 grams, Amlodipine 5 grams, Simvastatine 40 grams, Metformin 500 grams, and Gliclazide 30 grams, at the municipal health office.
Glucophage are available in hospitals while other salt of Gliclazide and Glibenclamide aren't available which patients have to bought from outside.
The first group (Group 1) consisted of patients that used metformin (1000 mg bid) and gliclazide (60 mg qd).
An unknown member of staff gave Margaret a box of Gliclazide marked for diabetic Florence.
And glibenclamide, gliquidone, gliclazide and glimepiride are the common drugs in the class of sulfonylurea.
Keywords: Diabetes Oral antidiabetic drugs Glimepiride Gliclazide Glipizide Glibenclamide.
The medicines were stolen with an iPad and some jewellery and include Citalopram, an anti-depressant, four boxes of Metformin, used to treat type two diabetes and four boxes of Gliclazide, also used for diabetes.
The medicines were stolen with an iPad and some jewellery and include Citalopram, an antidepressant, four boxes of Metformin, used to treat type two diabetes and four boxes of Gliclazide, also used for diabetes.
The drugs that will become cheaper would include atorvastatin, gliclazide, glimepiride, heparin and metolazone among others.
They were astonished that nothing had been prescribed for me in the past five years and I was immediately prescribed Gliclazide, to be taken twice a day.
They cover bio-encapsulation for the immune-protection of therapeutic cells, E-cadherin--Fc chimeric protein-based biomaterial: breaking the barriers in stem cell technology and regenerative medicine, advances in molecular technologies and platform for the diagnosis of infectious diseases, medical applications of fermentation technology, the formulation and analysis of the anti-diabetic agent gliclazide, and biomedical perspectives on polyaniline-based biosensors.